Correlation Between Petros Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petros Pharmaceuticals and Eliem Therapeutics, you can compare the effects of market volatilities on Petros Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Petros Pharmaceuticals and Eliem Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Petros and Eliem is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Petros Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Petros Pharmaceuticals is expected to under-perform the Eliem Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Petros Pharmaceuticals is 1.34 times less risky than Eliem Therapeutics. The stock trades about -0.41 of its potential returns per unit of risk. The Eliem Therapeutics is currently generating about -0.22 of returns per unit of risk over similar time horizon. If you would invest 392.00 in Eliem Therapeutics on August 31, 2024 and sell it today you would lose (88.00) from holding Eliem Therapeutics or give up 22.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Petros Pharmaceuticals vs. Eliem Therapeutics
Performance |
| Timeline |
| Petros Pharmaceuticals |
| Eliem Therapeutics |
Petros Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Petros Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Petros Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Petros Pharmaceuticals vs. Bausch Health Companies | Petros Pharmaceuticals vs. Haleon plc | Petros Pharmaceuticals vs. Intracellular Th |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |